Annual CAPEX
$58.81 M
-$34.18 M-36.76%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual capital expenditures is $58.81 million, with the most recent change of -$34.18 million (-36.76%) on December 31, 2023.
- During the last 3 years, NVAX annual CAPEX has risen by +$4.18 million (+7.66%).
- NVAX annual CAPEX is now -36.76% below its all-time high of $92.98 million, reached on December 31, 2022.
Performance
NVAX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$2.01 M
-$1.11 M-35.62%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly capital expenditures is $2.01 million, with the most recent change of -$1.11 million (-35.62%) on September 30, 2024.
- Over the past year, NVAX quarterly CAPEX has dropped by -$16.38 million (-89.06%).
- NVAX quarterly CAPEX is now -95.21% below its all-time high of $42.01 million, reached on December 31, 2020.
Performance
NVAX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$21.46 M
-$16.38 M-43.28%
September 30, 2024
Summary
- As of February 7, 2025, NVAX TTM capital expenditures is $21.46 million, with the most recent change of -$16.38 million (-43.28%) on September 30, 2024.
- Over the past year, NVAX TTM CAPEX has dropped by -$50.33 million (-70.10%).
- NVAX TTM CAPEX is now -78.47% below its all-time high of $99.72 million, reached on March 31, 2023.
Performance
NVAX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
NVAX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.8% | -89.1% | -70.1% |
| 3 y3 years | +7.7% | -87.7% | -62.7% |
| 5 y5 years | +4186.1% | +1549.2% | +1728.4% |
NVAX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | +2.3% | -93.2% | at low | -78.5% | at low |
| 5 y | 5-year | -36.8% | +3066.7% | -95.2% | +1549.2% | -78.5% | +1728.4% |
| alltime | all time | -36.8% | >+9999.0% | -95.2% | +435.3% | -78.5% | -100.0% |
Novavax CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.01 M(-35.6%) | $21.46 M(-43.3%) |
| Jun 2024 | - | $3.13 M(-56.9%) | $37.84 M(-11.0%) |
| Mar 2024 | - | $7.25 M(-20.1%) | $42.50 M(-27.7%) |
| Dec 2023 | $58.81 M(-36.8%) | $9.08 M(-50.6%) | $58.81 M(-18.1%) |
| Sep 2023 | - | $18.39 M(+136.4%) | $71.79 M(-13.4%) |
| Jun 2023 | - | $7.78 M(-67.0%) | $82.92 M(-16.8%) |
| Mar 2023 | - | $23.56 M(+6.8%) | $99.72 M(+7.2%) |
| Dec 2022 | $92.98 M(+61.8%) | $22.06 M(-25.3%) | $92.98 M(+6.5%) |
| Sep 2022 | - | $29.52 M(+20.1%) | $87.28 M(+24.8%) |
| Jun 2022 | - | $24.58 M(+46.1%) | $69.96 M(+15.6%) |
| Mar 2022 | - | $16.83 M(+2.8%) | $60.53 M(+5.3%) |
| Dec 2021 | $57.49 M(+5.2%) | $16.36 M(+34.2%) | $57.49 M(-30.9%) |
| Sep 2021 | - | $12.19 M(-19.5%) | $83.13 M(+4.3%) |
| Jun 2021 | - | $15.15 M(+9.9%) | $79.67 M(+16.7%) |
| Mar 2021 | - | $13.78 M(-67.2%) | $68.28 M(+25.0%) |
| Dec 2020 | $54.62 M(+2841.4%) | $42.01 M(+381.5%) | $54.62 M(+325.9%) |
| Sep 2020 | - | $8.73 M(+132.0%) | $12.83 M(+187.6%) |
| Jun 2020 | - | $3.76 M(+2983.6%) | $4.46 M(+279.9%) |
| Mar 2020 | - | $122.00 K(-43.5%) | $1.17 M(-36.8%) |
| Dec 2019 | $1.86 M(+35.3%) | $216.00 K(-40.0%) | $1.86 M(-13.9%) |
| Sep 2019 | - | $360.00 K(-24.4%) | $2.16 M(-1.6%) |
| Jun 2019 | - | $476.00 K(-40.9%) | $2.19 M(+8.2%) |
| Mar 2019 | - | $805.00 K(+55.7%) | $2.03 M(+47.7%) |
| Dec 2018 | $1.37 M(-67.2%) | $517.00 K(+30.6%) | $1.37 M(-8.6%) |
| Sep 2018 | - | $396.00 K(+28.2%) | $1.50 M(-35.6%) |
| Jun 2018 | - | $309.00 K(+106.0%) | $2.33 M(-28.4%) |
| Mar 2018 | - | $150.00 K(-76.8%) | $3.25 M(-22.3%) |
| Dec 2017 | $4.19 M(-77.0%) | $646.00 K(-47.3%) | $4.19 M(-37.8%) |
| Sep 2017 | - | $1.23 M(-0.7%) | $6.74 M(-28.9%) |
| Jun 2017 | - | $1.23 M(+13.8%) | $9.47 M(-31.2%) |
| Mar 2017 | - | $1.08 M(-66.1%) | $13.77 M(-24.4%) |
| Dec 2016 | $18.20 M(-0.4%) | $3.19 M(-19.4%) | $18.20 M(-7.3%) |
| Sep 2016 | - | $3.96 M(-28.3%) | $19.63 M(-2.2%) |
| Jun 2016 | - | $5.53 M(+0.2%) | $20.07 M(+6.1%) |
| Mar 2016 | - | $5.52 M(+19.4%) | $18.92 M(+3.6%) |
| Dec 2015 | $18.27 M(+151.3%) | $4.62 M(+4.8%) | $18.27 M(+13.9%) |
| Sep 2015 | - | $4.41 M(+0.7%) | $16.04 M(+9.4%) |
| Jun 2015 | - | $4.38 M(-10.0%) | $14.66 M(+30.4%) |
| Mar 2015 | - | $4.86 M(+103.4%) | $11.24 M(+54.7%) |
| Dec 2014 | $7.27 M(+25.6%) | $2.39 M(-21.1%) | $7.27 M(+23.2%) |
| Sep 2014 | - | $3.03 M(+216.7%) | $5.90 M(+31.9%) |
| Jun 2014 | - | $957.00 K(+7.6%) | $4.47 M(-12.8%) |
| Mar 2014 | - | $889.00 K(-13.1%) | $5.13 M(-11.3%) |
| Dec 2013 | $5.79 M(+33.3%) | $1.02 M(-36.3%) | $5.79 M(-16.2%) |
| Sep 2013 | - | $1.60 M(-0.6%) | $6.90 M(+7.5%) |
| Jun 2013 | - | $1.61 M(+4.7%) | $6.42 M(+25.7%) |
| Mar 2013 | - | $1.54 M(-27.9%) | $5.11 M(+17.7%) |
| Dec 2012 | $4.34 M(+611.6%) | $2.14 M(+90.0%) | $4.34 M(+81.0%) |
| Sep 2012 | - | $1.13 M(+270.4%) | $2.40 M(+59.0%) |
| Jun 2012 | - | $304.00 K(-60.6%) | $1.51 M(+12.5%) |
| Mar 2012 | - | $772.00 K(+293.9%) | $1.34 M(+119.8%) |
| Dec 2011 | $610.00 K | $196.00 K(-16.9%) | $610.00 K(+11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $236.00 K(+72.3%) | $546.00 K(-46.6%) |
| Jun 2011 | - | $137.00 K(+234.1%) | $1.02 M(+8.8%) |
| Mar 2011 | - | $41.00 K(-68.9%) | $939.00 K(-39.7%) |
| Dec 2010 | $1.56 M(+108.9%) | $132.00 K(-81.5%) | $1.56 M(-14.2%) |
| Sep 2010 | - | $712.00 K(+1218.5%) | $1.81 M(+40.7%) |
| Jun 2010 | - | $54.00 K(-91.8%) | $1.29 M(-3.8%) |
| Mar 2010 | - | $658.00 K(+69.2%) | $1.34 M(+79.9%) |
| Dec 2009 | $745.00 K(-86.9%) | $389.00 K(+106.9%) | $745.00 K(-25.1%) |
| Sep 2009 | - | $188.00 K(+79.0%) | $994.00 K(-37.2%) |
| Jun 2009 | - | $105.00 K(+66.7%) | $1.58 M(-61.6%) |
| Mar 2009 | - | $63.00 K(-90.1%) | $4.12 M(-27.6%) |
| Dec 2008 | $5.69 M(+190.1%) | $638.00 K(-18.0%) | $5.69 M(-0.6%) |
| Sep 2008 | - | $778.00 K(-70.6%) | $5.72 M(+6.8%) |
| Jun 2008 | - | $2.64 M(+62.0%) | $5.36 M(+76.5%) |
| Mar 2008 | - | $1.63 M(+143.1%) | $3.04 M(+54.8%) |
| Dec 2007 | $1.96 M(+39.5%) | $671.00 K(+61.3%) | $1.96 M(+25.1%) |
| Sep 2007 | - | $416.00 K(+30.8%) | $1.57 M(-3.5%) |
| Jun 2007 | - | $318.00 K(-42.8%) | $1.63 M(-6.3%) |
| Mar 2007 | - | $556.00 K(+100.0%) | $1.74 M(+23.4%) |
| Dec 2006 | $1.41 M(+1178.2%) | $278.00 K(-41.2%) | $1.41 M(+23.9%) |
| Sep 2006 | - | $473.00 K(+10.5%) | $1.14 M(+65.7%) |
| Jun 2006 | - | $428.00 K(+88.5%) | $685.00 K(+108.2%) |
| Mar 2006 | - | $227.00 K(+3142.9%) | $329.00 K(+199.1%) |
| Dec 2005 | $110.00 K(-93.2%) | $7000.00(-69.6%) | $110.00 K(-61.3%) |
| Sep 2005 | - | $23.00 K(-68.1%) | $284.00 K(-63.9%) |
| Jun 2005 | - | $72.00 K(+800.0%) | $786.00 K(-23.6%) |
| Mar 2005 | - | $8000.00(-95.6%) | $1.03 M(-36.0%) |
| Dec 2004 | $1.61 M(-20.3%) | $181.00 K(-65.5%) | $1.61 M(-34.2%) |
| Sep 2004 | - | $525.00 K(+66.7%) | $2.44 M(-2.3%) |
| Jun 2004 | - | $315.00 K(-46.3%) | $2.50 M(+21.2%) |
| Mar 2004 | - | $587.00 K(-42.2%) | $2.06 M(+2.2%) |
| Dec 2003 | $2.02 M(-79.1%) | $1.02 M(+74.3%) | $2.02 M(+6.4%) |
| Sep 2003 | - | $583.00 K(-574.0%) | $1.90 M(-48.9%) |
| Jun 2003 | - | -$123.00 K(-122.7%) | $3.71 M(-51.7%) |
| Mar 2003 | - | $542.00 K(-39.4%) | $7.69 M(-20.4%) |
| Dec 2002 | $9.66 M(+313.7%) | $895.00 K(-62.7%) | $9.66 M(-6.1%) |
| Sep 2002 | - | $2.40 M(-37.6%) | $10.29 M(+28.3%) |
| Jun 2002 | - | $3.85 M(+52.9%) | $8.02 M(+65.3%) |
| Mar 2002 | - | $2.52 M(+65.3%) | $4.85 M(+107.8%) |
| Dec 2001 | $2.33 M(+181.0%) | $1.52 M(+1062.6%) | $2.33 M(+129.8%) |
| Sep 2001 | - | $131.00 K(-80.8%) | $1.02 M(-1.1%) |
| Jun 2001 | - | $681.00 K(+233.8%) | $1.03 M(+23.6%) |
| Dec 2000 | $831.00 K(+315.5%) | $204.00 K(+43.7%) | $831.00 K(+2977.8%) |
| Sep 2000 | - | $142.00 K(-59.7%) | $27.00 K(-94.4%) |
| Jun 2000 | - | $352.00 K(+164.7%) | $485.00 K(+264.7%) |
| Mar 2000 | - | $133.00 K(-122.2%) | $133.00 K(>+9900.0%) |
| Dec 1999 | - | -$600.00 K(-200.0%) | $0.00(-100.0%) |
| Sep 1999 | - | $600.00 K(>+9900.0%) | $600.00 K(+200.0%) |
| Dec 1998 | $200.00 K(+100.0%) | $0.00(-100.0%) | $200.00 K(0.0%) |
| Sep 1998 | - | $100.00 K(>+9900.0%) | $200.00 K(+100.0%) |
| Jun 1998 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Mar 1998 | - | $100.00 K | $100.00 K |
| Dec 1996 | $100.00 K | - | - |
FAQ
- What is Novavax annual capital expenditures?
- What is the all time high annual CAPEX for Novavax?
- What is Novavax annual CAPEX year-on-year change?
- What is Novavax quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Novavax?
- What is Novavax quarterly CAPEX year-on-year change?
- What is Novavax TTM capital expenditures?
- What is the all time high TTM CAPEX for Novavax?
- What is Novavax TTM CAPEX year-on-year change?
What is Novavax annual capital expenditures?
The current annual CAPEX of NVAX is $58.81 M
What is the all time high annual CAPEX for Novavax?
Novavax all-time high annual capital expenditures is $92.98 M
What is Novavax annual CAPEX year-on-year change?
Over the past year, NVAX annual capital expenditures has changed by -$34.18 M (-36.76%)
What is Novavax quarterly capital expenditures?
The current quarterly CAPEX of NVAX is $2.01 M
What is the all time high quarterly CAPEX for Novavax?
Novavax all-time high quarterly capital expenditures is $42.01 M
What is Novavax quarterly CAPEX year-on-year change?
Over the past year, NVAX quarterly capital expenditures has changed by -$16.38 M (-89.06%)
What is Novavax TTM capital expenditures?
The current TTM CAPEX of NVAX is $21.46 M
What is the all time high TTM CAPEX for Novavax?
Novavax all-time high TTM capital expenditures is $99.72 M
What is Novavax TTM CAPEX year-on-year change?
Over the past year, NVAX TTM capital expenditures has changed by -$50.33 M (-70.10%)